Cytokines as Biomarkers and Their Respective Clinical Cutoff Levels

International Journal of Inflammation

Volumn 2017, Issue , 2017, Pages

  Monastero, Rebecca N ^a   Pentyala, Srinivas ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; INTERFERON; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR;

ALZHEIMER DISEASE; BLOOD CELL COUNT; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ARREST; HEART LEFT VENTRICLE FAILURE; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNODETECTION; LUPUS ERYTHEMATOSUS NEPHRITIS; PNEUMONIA; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 85018842123     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2017/4309485     Document Type: Review

References (59)

1. C. Dinarello, "Historical insights into cytokines, " European Journal of Immunology, vol. 37, supplement 1, pp. S34-S45, 2007.
2. D.-L. Su, Z.-M. Lu, M.-N. Shen, X. Li, L.-Y. Sun, "Roles of pro-A nd anti-inflammatory cytokines in the pathogenesis of SLE, " Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 347141, 2012.
3. L. M. O. Pinto, S. A. Oliveira, E. L. A. Braga, R. M. R. Nogueira, C. F. Kubelka, "Increased pro-inflammatory cytokines (TNF-A nd IL-6) and anti-inflammatory compounds (sTNFRp55 and sTNFRp75) in Brazilian patients during exanthematic dengue fever, " Memorias do Instituto Oswaldo Cruz, vol. 94, no. 3, pp. 387-394, 1999.
4. C. Marie, C. Pitton, C. Fitting, J.-M. Cavaillon, "Regulation by anti-inflammatory cytokines (IL-4, IL-10, IL-13, TGF) of interleukin-8 production by LPS-A nd/or TNF-activated human polymorphonuclear cells, " Mediators of Inflammation, vol. 5, no. 5, pp. 334-340, 1996.
5. J. M. Cavaillon, "Pro-versus anti-inflammatory cytokines:myth or reality, " Cellular andMolecular Biology, vol. 47, no. 4, pp. 695-702, 2001.
6. I. R. Williams, B. E. Rich, T. S. Kupper, "Cytokines, " in Fitzpatrick's Dermatology in General Medicine, K. Wolff, L. A. Goldsmith, S. I. Katz, B. A. Gilchrest, A. S. Paller, D. J. Leffel, Eds., pp. 115-126, McGraw-Hill, NewYork, NY, USA, 7th edition, 2008.
7. P. C. Heinrich, I. Behrmann, G. Müller-Newen, F. Schaper, L. Graeve, "Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway, " Biochemical Journal, vol. 334, no. 2, pp. 297-314, 1998.
8. M. S. Hayden and S. Ghosh, "Shared principles in NF-B signaling, " Cell, vol. 132, no. 3, pp. 344-362, 2008.
9. P. Conti, D. Kempuraj, K. Kandere, et al., "IL-10, an inflammatory/inhibitory cytokine, but not always, " Immunology Letters, vol. 86, no. 2, pp. 123-129, 2003.
10. J. Scheller, A. Chalaris, D. Schmidt-Arras, S. Rose-John, "The pro-A nd anti-inflammatory properties of the cytokine interleukin-6, " Biochimica et Biophysica Acta, vol. 1813, no. 5, pp. 878-888, 2011.
11. D. M. Mosser and X. Zhang, "Interleukin-10: New perspectives on an old cytokine, " Immunological Reviews, vol. 226, no. 1, pp. 205-218, 2008.
12. X. Zhou, M. S. Fragala, J. E. McElhaney, G. A. Kuchel, "Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research, " Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 5, pp. 541-547, 2010.
13. H. O. Kim, H.-S. Kim, J.-C. Youn, E.-C. Shin, S. Park, "Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays, " Journal of Translational Medicine, vol. 9, no. 1, article 113, 2011.
14. G. Kleiner, A. Marcuzzi, V. Zanin, L. Monasta, G. Zauli, "Cytokine levels in the serum of healthy subjects, " Mediators of Inflammation, vol. 2013, Article ID 434010, 2013.
15. P. Chapman, C. Reyes, V. Gupta, "Normal physiological levels of human cytokines using Bio-Plex Pro Cytokine Assays, " Bio-Rad Bulletin: Technical Note 6029, rev. A, 2010.
16. J. Bienvenu, G. Monneret, N. Fabien, J. P. Revillard, "The clinical usefulness of the measurement of cytokines, " Clinical Chemistry and Laboratory Medicine, vol. 38, no. 4, pp. 267-285, 2000.
17. S. X. Leng, J. E. McElhaney, J. D. Walston, D. Xie, N. S. Fedarko, G. A. Kuchel, "ELISA and multiplex technologies for cytokinemeasurement in inflammation and aging research, " Journals of Gerontology. Series A Biological Sciences andMedical Sciences, vol. 63, no. 8, pp. 879-884, 2008.
18. G. Liu, M. Qi, M. R. Hutchinson, G. Yang, E. M. Goldys, "Recent advances in cytokine detection by immunosensing, " Biosensors and Bioelectronics, vol. 79, pp. 810-821, 2016.
19. T. Fawcett, "An introduction to ROC analysis, " Pattern Recognition Letters, vol. 27, no. 8, pp. 861-874, 2006.
20. J. Fan, S. Upadhye, A. Worster, "Understanding receiver operating characteristic (ROC) curves, " Canadian Journal of Emergency Medicine, vol. 8, no. 1, pp. 19-20, 2006.
21. C.-F. Wong, W.-W. Yew, S. K.-F. Leung, et al., "Assay of pleural fluid interleukin-6, tumuor necrosis factor-alpha and interferon-gamma in the diagnosis and outcome correlation of tuberculous effusion, " Respiratory Medicine, vol. 97, no. 12, pp. 1289-1295, 2003.
22. S. K. Sharma and A. Banga, "Diagnostic utility of pleural fluid IFN-in tuberculosis pleural effusion, " Journal of Interferonand Cytokine Research, vol. 24, no. 4, pp. 213-217, 2004.
23. S. K. Sharma, M. Tahir, A. Mohan, D. Smith-Rohrberg, H. K. Mishra, R. M. Pandey, "Diagnostic accuracy of ascitic fluid IFN-A nd adenosine deaminase assays in the diagnosis of tuberculous ascites, " Journal of Interferon and Cytokine Research, vol. 26, no. 7, pp. 484-488, 2006.
24. E. Küpeli, D. Karnak, S. Beder, O. Kayacan, H. Tutkak, "Diagnostic accuracy of cytokine levels (TNF-, IL-2 and IFN-) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients, " Respiration, vol. 75, no. 1, pp. 73-78, 2008.
25. C.-C. Shu, J.-Y. Wang, C.-L. Hsu, et al., "Diagnostic role of inflammatory and anti-inflammatory cytokines and effector molecules of cytotoxic T lymphocytes in tuberculous pleural effusion, " Respirology, vol. 20, no. 1, pp. 147-154, 2015.
26. P. Raḿrez, M. Ferrer, R. Gimeno, et al., "Systemic inflammatory response and increased risk for ventilator-associated pneumonia: A preliminary study, " Critical Care Medicine, vol. 37, no. 5, pp. 1691-1695, 2009.
27. A. C. Morris, K. Kefala, T. S. Wilkinson, et al., "Diagnostic importance of pulmonary interleukin-1 and interleukin-8 in ventilator-associated pneumonia, " Thorax, vol. 65, no. 3, pp. 201-207, 2010.
28. W.-L. Su, W.-C. Perng, C.-H. Huang, et al., "Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia, " Clinical and Vaccine Immunology, vol. 17, no. 5, pp. 771-777, 2010.
29. P. V. Giannoudis, P. J. Harwood, P. Loughenbury, M. Van Griensven, C. Krettek, H.-C. Pape, "Correlation between IL-6 levels and the systemic inflammatory response score: Can an IL-6 cutoff predict a SIRS state"The Journal of Trauma, vol. 65, no. 3, pp. 646-652, 2008.
30. P. C. Ng, S. H. Cheng, K. M. Chui, et al., "Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, C-reactive protein in preterm very low birthweight infants, " Archives ofDisease inChildhood: Fetal andNeonatal Edition, vol. 77, no. 3, pp. F221-F227, 1997.
31. G. Laborada, M. Rego, A. Jain, et al., "Diagnostic value of cytokines and c-reactive protein in the first 24 hours of neonatal sepsis, " American Journal of Perinatology, vol. 20, no. 8, pp. 491-501, 2003.
32. H. Boskabadi, G. Maamouri, J. T. Afshari, et al., "Evaluation of serum interleukins-6, 8 and 10 levels as diagnostic markers of neonatal infection and possibility of mortality, " Iranian Journal of Basic Medical Sciences, vol. 16, no. 12, pp. 1232-1237, 2013.
33. C. Sherwin, R. Broadbent, S. Young, et al., "Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis, " American Journal of Perinatology, vol. 25, no. 10, pp. 629-636, 2008.
34. H. Boskabadi, G. Maamouri, J. T. Afshari, M. Ghayour-Mobarhan, M.-T. Shakeri, "Serum interleukin 8 level as a diagnostic marker in late neonatal sepsis, " Iranian Journal of Pediatrics, vol. 20, no. 1, pp. 41-47, 2010.
35. H. Boskabadi, G. A. Maamouri, M. Ghayour-Mobarhan, J. Tavakkol Afshari, M. T. Shakeri, G. A. A. Ferns, "Early diagnosis of late neonatal sepsis by measuring interleukin 10: A case control study, " Journal of Neonatology, vol. 25, no. 2, pp. 82-86, 2011.
36. S. J. Frangiamore, A. Saleh, M. F. Kovac, et al., "Synovial fluid interleukin-6 as a predictor of periprosthetic shoulder infection, " The Journal of Bone & Joint Surgery-American Volume, vol. 97, no. 1, pp. 63-70, 2015.
37. S. J. Frangiamore, M. P. Siqueira, A. Saleh, T. Daly, C. A. Higuera, W. K. Barsoum, "Synovial cytokines and the MSIS criteria are not useful for determining infection resolution after periprosthetic joint infection explantation, " Clinical Orthopaedics and Related Research, vol. 474, no. 7, pp. 1630-1639, 2016.
38. A. Candau-Alvarez, M. Gil-Campos, M. J. De La Torre-Aguilar, F. Llorente-Cantarero, J. Lopez-Miranda, J. L. Perez-Navero, "Early modification in drainage of interleukin-1 and tumor necrosis factor-best predicts surgical-site infection after cervical neck dissection for oral cancer, " Journal of Oral and Maxillofacial Surgery, vol. 73, no. 6, pp. 1189-1198, 2015.
39. J. Szkodzinski, B. Hudzik, M. Osuch, et al., "Serum concentrations of interleukin-4 and interferon-gamma in relation to severe left ventricular dysfunction in patients with acutemyocardial infarction undergoing percutaneous coronary intervention, " Heart and Vessels, vol. 26, no. 4, pp. 399-407, 2011.
40. R. Caruso, L. Botta, A. Verde, et al., "Relationship between preimplant interleukin-6 levels, inflammatory response, early outcome in patients supported by left ventricular assist device: A prospective study, " PLoS ONE, vol. 9, no. 3, Article ID e90802, 2014.
41. S. M. Dayana, S. M. Lim, M. P. Tan, et al., "115 IP-10 and IL-13 as potentially new, non-classical blood-based cytokine biomarkers for Alzheimer's disease, " Age and Ageing, vol. 43, supplement 1, pp. i32-i32, 2014.
42. D. S. Mohd Hasni, S. M. Lim, A. V. Chin, et al., "Peripheral cytokines, C-X-C motif ligand10 and interleukin-13, are associated with Malaysian Alzheimer's disease, " Geriatrics and Gerontology International, 2016.
43. Y. Oda, R. Tsuruta, S. Kasaoka, T. Inoue, T. Maekawa, "The cutoff values of intrathecal interleukin 8 and 6 for predicting the neurological outcome in cardiac arrest victims, " Resuscitation, vol. 80, no. 2, pp. 189-193, 2009.
44. T. Ashizawa, R. Okada, Y. Suzuki, et al., "Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: Role of IL-6 as a prognostic factor, " Gastric Cancer, vol. 8, no. 2, pp. 124-131, 2005.
45. D.-K. Kim, S. Y. Oh, H.-C. Kwon, et al., "Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer, "BMC Cancer, vol. 9, article 155, 2009.
46. S. Torabinejad, R. Mardani, Z. Habibagahi, et al., "Urinary monocyte chemotactic protein-1 and transforming growth factor-in systemic lupus erythematosus, " Indian Journal of Nephrology, vol. 22, no. 1, pp. 5-12, 2012.
47. S. M. Abdel Galil, N. Ezzeldin, M. E. El-Boshy, "The role of serum IL-17 and IL-6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis, " Cytokine, vol. 76, no. 2, pp. 280-287, 2015.
48. X. Xu, Y. Tang, H. Song, S. Yang, W. Xu, N. Zhao, "Original article: Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children, " The Journal of Pediatrics, vol. 160, no. 6, pp. 984-990, 2012.
49. M. A. Bedaiwy, T. Falcone, R. K. Sharma, et al., "Prediction of endometriosis with serum and peritoneal fluid markers: A prospective controlled trial, " Human Reproduction, vol. 17, no. 2, pp. 426-431, 2002.
50. C. Tortorella, G. Piazzolla, M. Matteo, et al., "Interleukin-6, interleukin-1, tumor necrosis factor in menstrual effluents as biomarkers of chronic endometritis, " Fertility and Sterility, vol. 101, no. 1, pp. 242-247, 2014.
51. M. Chechlinska, J. Kaminska, J. Markowska, A. Kramar, J. Steffen, "Peritoneal fluid cytokines and the differential diagnosis of benign andmalignant ovarian tumors and residual/recurrent disease examination, " International Journal of Biological Markers, vol. 22, no. 3, pp. 172-180, 2007.
52. E. Gorelik, D. P. Landsittel, A. M. Marrangoni, et al., "Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer, " Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 4, pp. 981-987, 2005.
53. D. Soriano, D. Hugol, N. T. Quang, E. Darai, "Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, tumor necrosis factor alpha in patients with ectopic pregnancy, " Fertility and Sterility, vol. 79, no. 4, pp. 975-980, 2003.
54. S. Rajendiran, G. P. Senthil Kumar, A. Nimesh, P. Dhiman, K. Shivaraman, S. Soundararaghavan, "Diagnostic significance of IL-6 and IL-8 in tubal ectopic pregnancy, " Journal of Obstetrics and Gynaecology, vol. 36, no. 7, pp. 909-911, 2016.
55. M. Kacerovsky, I. Musilova, H. Hornychova, et al., "Bedside assessment of amniotic fluid interleukin-6 in preterm prelabor rupture of membranes, " American Journal of Obstetrics and Gynecology, vol. 211, no. 4, pp. 385. e1-385. e9, 2014.
56. I. Musilova, T. Bestvina, M. Hudeckova, et al., "Vaginal fluid IL-6 concentrations as a point-of-care test is of value in women with preterm PROM, " American Journal of Obstetrics and Gynecology, vol. 215, no. 5, pp. 619. e1-619. e12, 2016.
57. A. Woodworth, J. Moore, C. G'Sell, et al., "Diagnostic accuracy of cervicovaginal interleukin-6 and interleukin-6:albumin ratio as markers of preterm delivery, " Clinical Chemistry, vol. 53, no. 8, pp. 1534-1540, 2007.
58. S. B. Gandevani, A. Garshasbi, S. Faghih-Zadeh, T. Ghazanfari, "Te value of interleukin-8 and interleukin-6 in cervical secretions as predictors of preterm delivery, " Iranian Journal of Pathology, vol. 6, no. 1, pp. 20-26, 2011.
59. Z. Shahshahan and L. Hashemi, "Maternal serum cytokines in the prediction of preterm labor and response to tocolytic therapy in preterm labor women, " Advanced Biomedical Research, vol. 3, no. 126, 2014.